Altered P53 conformation: A novel mechanism of wild-type p53 functional inactivation in a model for early human breast cancer

被引:0
|
作者
Shekhar, PVM
Welte, R
Christman, JK
Wang, H
Werdell, J
机构
[1] KARMANOS CANC INST,DEPT PATHOL,DETROIT,MI 48201
[2] WAYNE STATE UNIV,SCH MED,DETROIT,MI 48201
[3] UNIV ULM,SCH MED,UNIT PUBL HLTH,D-89081 ULM,GERMANY
[4] UNIV NEBRASKA,MED CTR,UNMC EPPLEY CANC CTR,OMAHA,NE 68198
[5] UNIV NEBRASKA,MED CTR,EPPLEY INST RES CANC,OMAHA,NE 68198
关键词
MCF10A; T24; Ha-ras; xenograft model; conformationally altered wild-type P53; preneoplasia;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The p53 protein is a transcription factor that is frequently mutated in human malignancies. Using the MCF10AT model for early human breast cancer we show that P53 protein is unmutated indicating that mutations are not necessary for alterations in growth and morphology that accompany preneoplastic stages of breast tumor progression. Although p53 protein is wild-type in cells of the MCF10AT model system, it exists predominantly in a conformationally altered state that is defective in its ability both to bind DNA in a sequence-specific manner and to induce transcriptional activation from the WAF-1 promoter. This contrasts with P53 from the non-tumorigenic parental MCF10A cells which is predominantly conformationally normal and functionally active. The possibility that stabilized wild-type but conformationally altered P53 plays a role in the neoplastic progression of preneoplastic MCF10AT system cells is discussed.
引用
收藏
页码:1087 / 1094
页数:8
相关论文
共 50 条
  • [11] Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein
    Vinyals, A
    Peinado, MA
    Gonzalez-Garrigues, M
    Monzó, M
    Bonfil, RD
    Fabra, A
    GENE THERAPY, 1999, 6 (01) : 22 - 33
  • [12] Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts
    Watanabe, T
    Sullenger, BA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (15) : 8490 - 8494
  • [13] TUMOR SUPPRESSOR P53 - ANALYSIS OF WILD-TYPE AND MUTANT P53 COMPLEXES
    MILNER, J
    MEDCALF, EA
    COOK, AC
    MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (01) : 12 - 19
  • [14] P53 GENE-MUTATIONS IN HUMAN GASTRIC-CANCER - WILD-TYPE P53 BUT NOT MUTANT P53 SUPPRESSES GROWTH OF HUMAN GASTRIC-CANCER CELLS
    MATOZAKI, T
    SAKAMOTO, C
    SUZUKI, T
    MATSUDA, K
    UCHIDA, T
    NAKANO, O
    WADA, K
    NISHISAKI, H
    KONDA, Y
    NAGAO, M
    KASUGA, M
    CANCER RESEARCH, 1992, 52 (16) : 4335 - 4341
  • [15] WILD-TYPE P53 SUPPRESSES THE MALIGNANT PHENOTYPE IN BREAST-CANCER CELLS CONTAINING MUTANT P53 ALLELES
    RUNNEBAUM, IB
    YEE, JK
    KIEBACK, DG
    SUKUMAR, S
    FRIEDMANN, T
    ANTICANCER RESEARCH, 1994, 14 (3A) : 1137 - 1144
  • [16] MUTANT p53 ALLELES CAN BE RESTORED TO THE WILD-TYPE CONFORMATION
    不详
    CANCER DISCOVERY, 2012, 2 (07) : 581 - 581
  • [17] TEMPERATURE SENSITIVITY FOR CONFORMATION IS AN INTRINSIC PROPERTY OF WILD-TYPE P53
    HAINAUT, P
    BUTCHER, S
    MILNER, J
    BRITISH JOURNAL OF CANCER, 1995, 71 (02) : 227 - 231
  • [18] Inactivation of wild-type p53 tumor suppressor by electrophilic prostaglandins
    Moos, PJ
    Edes, K
    Fitzpatrick, FA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (16) : 9215 - 9220
  • [19] Activities of wild-type and mutant p53
    Vousden, Karen H.
    CANCER RESEARCH, 2013, 73
  • [20] Flavonoids activate wild-type p53
    Plaumann, B
    Fritsche, M
    Rimpler, H
    Brandner, G
    Hess, RD
    ONCOGENE, 1996, 13 (08) : 1605 - 1614